Abasi Ene-Obong

From Disrupting Africa
Jump to: navigation, search
Abasi Ene-Obong
Abasi Ene-Obong.jpeg
Abasi Ene-Obong. Image retrieved from Impact Africa Summit on 28 May, 2021.
Born
Calabar, Nigeria
NationalityNigerian
Alma materUniversity of London
OccupationEntrepreneur
Known forBeing the Co-founder & CEO of 54gene
WebsiteLinkedIn

Editor: Charissa Cassels

Dr Abasi Ene-Obong cofounded 54gene and is the CEO of the company[1] 54gene is a Nigerian genomics startup[2] that aims to transform genetic information into solutions for improving human health. The company was launched in January, 2019.

Dr Ene-Obong has experience in the United States, United Kingdom and Nigerian healthcare industries. He has worked with leading healthcare organisations including Fortune 100 pharmaceutical companies, academic and research institutions and governments.[3]

He is passionate about Nigerian’s public health sector and prioritizing it during the global pandemic.[4]

Dr Ene-Obong is also the co-founder and CEO of Stack Diagnostics that was founded in July, 2018.[5]

History

He was born in Calabar, Nigeria.[6]

Education

He received a Master of Business Management and Bioscience Management degree from Keck Graduate Institute in California. The courses he took included International Business, Bioscience Business, Financial Accounting, Corporate Finance, Strategy, Marketing Management and Entrepreneurship. Additionally, Dr Ene-Obong has a master’s degree in business administration from Claremont College in California.[7] He received his PhD from the Barts and the London School of Medicine and Dentistry as well as a doctorate in cancer biology from the University of London.[8]

Dr Ene-Obong received his Master of Science degree in Human Molecular Genetics from 2008 to 2009 from Imperial College London. In that same year, he was an Honorary Research Associate at the Institute of Psychiatry at King’s College London in London, United Kingdom. He later became a Doctoral Researcher at the Barts Cancer Institute from October 2010 to March 2013 in London.

Career

He was a consultant for Gilead Sciences, a biotechnology company in the Greater Los Angeles region from September 2013 to April 2014, and became a Strategy Consultant at Panasonic, an electronics industry company, in November 2013.

He was a Research Manager for the IMS Institute for Healthcare Informatics in June 2014 as well as a Consultant for IMS Health that same year.

The following year saw him being a Senior Associate in the Health Industries Advisory for PwC in the Greater Chicago Area.[9] PwC is a network of firms that are committed to delivering quality assurance, advisory and tax services.[10]

He then worked for PharmAccess Foundation from November 2016 to December 2016.[11]

Dr Ene-Obong was a Lead Consultant in Nigeria’s Strategic Health Development Plan for Pathfinder International, from July 2017 to September 2017 in Nigeria.[12] Pathfinder International aims to champion sexual and reproductive health and rights worldwide, mobilizing communities that need a healthier future.[13]

Dr Ene-Obong has been 54gene’s CEO since January 2019.

Dr Ene-Obong aims to build the first and largest biobank of African DNA for Africa.[14] He wants to bridge the gap in genetic information and make African genomics available to the world to power drug discoveries that can treat people of all races.[15]

His goal is to study African genetics and to translate his insights into products that will help people.[16]

Awards and Achievements

He is part of the African Centre for Translational Genomics, an initiative that was established to facilitate translational genomics research by African scientists[17] and published a seminal paper on pancreatic cancer immunology in Gastroenterology.[18]

He was listed as 1 of the 30 most innovative entrepreneurs of the African continent[19] on 19 September,[20] 2019 by Quartz Africa.

In September, 2020, he was listed as a Nigerian hero in the fight against Covid-19 by a Nigerian newspaper, ThisDay,[21] and was included in Fortune’s 40 under 40 most influential people in healthcare for 2020. In that same year, he was selected to join the Global Endeavor Entrepreneur Network.[22]

References

  1. 54gene Closes $15M Series A - PR Newswire. Retrieved 26 May, 2021.
  2. 54gene Raises $15 million in Series A funding - CoinPedia. Retrieved 26 May, 2021.
  3. Abasi Ene-Obong - LinkedIn. Retrieved 27 May, 2021.
  4. Nigerian genomics startup 54gene launches COVID-19 testing support fund - Disrupt Africa. Retrieved 27 May, 2021.
  5. Abasi Ene-Obong - Crunch Base. Retrieved 28 May, 2021.
  6. Only 2% of genomic material available for research comes from Africa; 54gene wants to change that - Tech Crunch. Retrieved 27 May, 2021.
  7. Nigerian healthtech platform 54gene secures $4.5m - Venture Burn. Retrieved 27 May, 2021.
  8. Nigerian healthtech platform 54gene secures $4.5m - Venture Burn. Retrieved 27 May, 2021.
  9. Abasi Ene-Obong - LinkedIn. Retrieved 27 May, 2021.
  10. About Us - PwC. Retrieved 28 May, 2021.
  11. Abasi Ene-Obong - Topio Networks. Retrieved 28 May, 2021.
  12. Abasi Ene-Obong - LinkedIn. Retrieved 27 May, 2021.
  13. Who we are - Pathfinder International. Retrieved 28 May, 2021.
  14. Only 2% of genomic material available for research comes from Africa; 54gene wants to change that - Tech Crunch. Retrieved 27 May, 2021.
  15. The Massive, Overlooked Potential of African DNA - Wired. Retrieved 27 May, 2021.
  16. The next chapter for African genomics - Nature. Retrieved 27 May, 2021.
  17. Meet 54Gene: Changing The Landscape Of Global DNA By Including Africa - Forbes. Retrieved 26 May, 2021.
  18. The next chapter for African genomics - Nature. Retrieved 27 May, 2021.
  19. Abasi Ene Obong - Impact Africa Summit. Retrieved 28 May, 2021.
  20. Quartz Africa Innovators 2019: leading the change for Africa’s future - Quartz Africa. Retrieved 31 May, 2021.
  21. Dr Abasi Ene-Obong - Africa Tech Summit. Retrieved 20 July, 2021.
  22. Abasi Ene-Obong - Impact Africa Summit. Retrieved 28 May, 2021.